Basic fibroblast growth factor (Kyoto University)

N/A

Report date: 2022/01/24 13:25:21

Base Information

Drug NameBasic fibroblast growth factor (Kyoto University)

Drug Alias NamebFGF (Kyoto University)FGF-19XhFGF-21

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionFibroblast growth factor receptors agonists

TargetsFibroblast growth factor receptors

Therapy Area/IndicationsPeripheral Arterial Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesKyoto University

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesKyoto University

Active IndicationsN/A

Inactive IndicationsPeripheral Arterial Disease

ATC CodeN/A